TW200731972A - Methods and compositions for bactericide, bacteriostatic and anti-inflammation - Google Patents

Methods and compositions for bactericide, bacteriostatic and anti-inflammation

Info

Publication number
TW200731972A
TW200731972A TW095107622A TW95107622A TW200731972A TW 200731972 A TW200731972 A TW 200731972A TW 095107622 A TW095107622 A TW 095107622A TW 95107622 A TW95107622 A TW 95107622A TW 200731972 A TW200731972 A TW 200731972A
Authority
TW
Taiwan
Prior art keywords
bactericide
bacteriostatic
inflammation
compositions
methods
Prior art date
Application number
TW095107622A
Other languages
English (en)
Other versions
TWI365743B (en
Inventor
Hua-Lin Wu
Guey-Yueh Shi
Chuan-Chi Chiang
Hui-Pin Su
Original Assignee
Hua-Lin Wu
Guey-Yueh Shi
Chuan-Chi Chiang
Hui-Pin Su
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hua-Lin Wu, Guey-Yueh Shi, Chuan-Chi Chiang, Hui-Pin Su filed Critical Hua-Lin Wu
Publication of TW200731972A publication Critical patent/TW200731972A/zh
Application granted granted Critical
Publication of TWI365743B publication Critical patent/TWI365743B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
TW095107622A 2006-02-24 2006-03-07 Methods and compositions for bactericide, bacteriostatic and anti-inflammation TWI365743B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/361,589 US7939567B2 (en) 2006-02-24 2006-02-24 Dextromethorphan-based method for treating acne

Publications (2)

Publication Number Publication Date
TW200731972A true TW200731972A (en) 2007-09-01
TWI365743B TWI365743B (en) 2012-06-11

Family

ID=38437685

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095107622A TWI365743B (en) 2006-02-24 2006-03-07 Methods and compositions for bactericide, bacteriostatic and anti-inflammation

Country Status (13)

Country Link
US (1) US7939567B2 (zh)
EP (1) EP1986620B1 (zh)
JP (1) JP5347195B2 (zh)
KR (1) KR101279196B1 (zh)
CN (1) CN101023947B (zh)
AT (1) ATE539749T1 (zh)
AU (1) AU2006338583B8 (zh)
BR (1) BRPI0621210A2 (zh)
CA (1) CA2643277A1 (zh)
IL (1) IL193628A0 (zh)
TW (1) TWI365743B (zh)
WO (1) WO2007097765A1 (zh)
ZA (1) ZA200806703B (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8461102B2 (en) * 2010-03-02 2013-06-11 George E. Royster, JR. Methods and compositions for treating and preventing symptoms of hormonal variations
EP2566478A4 (en) * 2010-05-03 2014-04-30 Tsh Biopharm Corp Ltd PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING HYPERTENSION
DE11786796T8 (de) * 2010-05-27 2013-04-25 Hasumi Kenichiro Antigenpeptid und verwendung davon
JP6072789B2 (ja) * 2011-07-28 2017-02-01 イアン・エス・ザゴン 上皮創傷の処置のための方法及び組成物
US20150352100A1 (en) * 2013-01-21 2015-12-10 Avant Derma Pte. Ltd. Use of selective delta-opioid receptor antagonists and specific sensory receptor ligands
CA2947027A1 (en) * 2014-05-01 2015-11-05 Anterios, Inc. Methods to treat, prevent, and improve skin conditions
CN110198703A (zh) 2016-11-21 2019-09-03 艾里奥治疗公司 大试剂的透皮递送
CN106801037B (zh) * 2017-01-06 2021-01-19 中国人民解放军南京军区福州总医院 体外痤疮炎症模型的建立方法及其应用
US20230241029A1 (en) * 2018-12-11 2023-08-03 Kristoffer Hellstrand Methods of reducing post-surgical metastasis
CN114409673B (zh) * 2022-01-04 2023-08-08 广东克冠达医药科技有限公司 一种吗啡喃类化合物及其制备方法与应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2676177A (en) * 1949-11-09 1954-04-20 Hoffmann La Roche Process for the preparation of optically active 3-methoxy-n-methyl morphinans and salts thereof
CA1214393A (en) * 1984-06-26 1986-11-25 Eric L. Nelson Composition useful in the treatment of diarrhea
EP0506477B1 (en) * 1991-03-28 1999-06-23 Merck & Co. Inc. Vascular endothelial cell growth factor C subunit
US5366980A (en) * 1991-06-17 1994-11-22 Smith Richard A Use of dextromethorphan and an oxidase inhibitor to treat dermatitis
US5206248A (en) * 1992-03-27 1993-04-27 Smith Richard A Method for reducing emotional lability
US5260066A (en) * 1992-01-16 1993-11-09 Srchem Incorporated Cryogel bandage containing therapeutic agent
US5834480A (en) * 1997-06-13 1998-11-10 Elkhoury; George F. Topical application of opioids for treatment of acne and sebaceous gland disorders
US5994330A (en) * 1998-11-09 1999-11-30 El Khoury; Georges F. Topical application of muscarinic agents such as neostigmine for treatment of acne and other inflammatory conditions
DK2283842T3 (en) * 2000-02-08 2015-05-26 Euro Celtique Sa Oral opioid agonist formulations secured against forgery
CN1200709C (zh) * 2003-01-23 2005-05-11 张以成 氢溴酸右美沙芬滴丸及其制备方法

Also Published As

Publication number Publication date
AU2006338583A1 (en) 2007-08-30
EP1986620A1 (en) 2008-11-05
ATE539749T1 (de) 2012-01-15
EP1986620A4 (en) 2009-11-25
CA2643277A1 (en) 2007-08-30
JP2009527553A (ja) 2009-07-30
US20070203164A1 (en) 2007-08-30
AU2006338583B2 (en) 2011-12-22
BRPI0621210A2 (pt) 2011-12-06
KR101279196B1 (ko) 2013-06-26
EP1986620B1 (en) 2012-01-04
KR20080106183A (ko) 2008-12-04
CN101023947A (zh) 2007-08-29
WO2007097765A1 (en) 2007-08-30
IL193628A0 (en) 2009-08-03
JP5347195B2 (ja) 2013-11-20
TWI365743B (en) 2012-06-11
US7939567B2 (en) 2011-05-10
AU2006338583B8 (en) 2012-01-12
ZA200806703B (en) 2009-09-30
CN101023947B (zh) 2012-10-31

Similar Documents

Publication Publication Date Title
TW200731972A (en) Methods and compositions for bactericide, bacteriostatic and anti-inflammation
TW200738688A (en) Compounds for the treatment of inflammatory disorders
RS52823B (en) NEW UNITS USEFUL FOR TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES
TW200616620A (en) Compounds for the treatment of inflammatory disorders
WO2008064018A8 (en) Thienopyrimidinones for treatment of inflammatory disorders and cancers
NZ585460A (en) Inhibitors of human phosphatidyl-inositol 3-kinase delta
RS53617B1 (en) NEW UNITS USEFUL FOR TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES
SG170024A1 (en) Imidazole-based compounds, compositions comprising them and methods of their use
MY149577A (en) Cytokine inhibitors
TW200602313A (en) Anti-cytokine heterocyclic compounds
ATE529430T1 (de) Caspase-hemmer-propharmaka
WO2005108387A3 (en) Cytokine inhibitors
IL179607A0 (en) Indoles useful in the treatment of inflammation
MX2008001546A (es) 3,11b-cis-dihidrotetrabenazina para el tratamiento de una enfermedad proliferativa o una inflamacion.
HK1112920A1 (en) Macrolides with anti-inflammatory activity
GEP20146125B (en) Aminopyrimidines as syk inhibitors
GEP20135912B (en) 1-benzyl-3- hydroxymethylindazole derivatives and use thereat treatment of diseases based on mcp-1, cx3cr1 and p40 expression
MX2009004019A (es) Compuestos heteroarilo, composiciones de los mismos, y uso de los mismos como inhibidores de proteina cinasa.
TNSN05197A1 (en) Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation -and immunologically- mediated diseases
TN2010000038A1 (en) Organic compounds
MX2012002641A (es) Inhibidores de cinasa janus (jak).
GEP20135913B (en) 1-benzyl-3-hydroxymethylindazole derivatives and use thereat treatment of diseases based on mcp-1 and cx3cr1 expression
ATE427315T1 (de) Neue makrolide
ATE460410T1 (de) 2-arylcarbamoyl-indole als zytokinhemmer
HK1120216A1 (en) The use of bupropion metabolites for the treatment of inflammatory disorders